Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients.
about
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisIntegration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samplesOCTN cation transporters in health and disease: role as drug targets and assay development.Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil.
P2860
Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Serum carnitine levels and lev ...... Huntington's disease patients.
@en
Serum carnitine levels and lev ...... Huntington's disease patients.
@nl
type
label
Serum carnitine levels and lev ...... Huntington's disease patients.
@en
Serum carnitine levels and lev ...... Huntington's disease patients.
@nl
prefLabel
Serum carnitine levels and lev ...... Huntington's disease patients.
@en
Serum carnitine levels and lev ...... Huntington's disease patients.
@nl
P2093
P2860
P1476
Serum carnitine levels and lev ...... Huntington's disease patients
@en
P2093
Andrea A Sellers
Elaine M Frank
Miroslav Cuturic
Robert R Moran
Ruth K Abramson
P2860
P2888
P356
10.1007/S10072-012-0952-X
P50
P577
2013-01-01T00:00:00Z